The Anti CCP Test detects antibodies directed against cyclic citrullinated peptides, which are highly specific markers for rheumatoid arthritis (RA). It plays a crucial role in the early diagnosis of RA, often detecting disease presence before significant joint damage occurs. The presence of Anti CCP antibodies not only confirms RA but also indicates a more aggressive disease course, necessitating prompt and intensive treatment. The test is done via a blood sample and is used alongside other clinical findings, such as rheumatoid factor levels and radiographic imaging, to ensure accurate diagnosis. Early detection through Anti CCP testing allows healthcare providers to initiate disease-modifying antirheumatic drugs (DMARDs) early, slowing disease progression and improving long-term joint health and patient quality of life.
100% Safe & Secure
Same Day Sample Collection
Digital Reports Available